Weigang Dong
Overview
Explore the profile of Weigang Dong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
16
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dong W, Yin Y, Liu B, Jiang Y, Wang L, Shi D, et al.
Front Oncol
. 2024 Mar;
14:1179232.
PMID: 38515570
Background: The first-line standard treatment option for patients with NSCLC complicated with Chronic obstructive pulmonary disease (COPD) is still unclear and relies on the treatment option of NSCLC alone. To...
2.
Dong W, Yin Y, Yang S, Liu B, Chen X, Wang L, et al.
BMC Cancer
. 2024 Jan;
24(1):153.
PMID: 38291354
Background: Neoadjuvant immune checkpoint inhibitors(ICIs) combined with chemotherapy can improve non-small cell lung cancer(NSCLC) patients' pathological responses and show promising improvements in survival. Chronic obstructive pulmonary disease (COPD) is a...
3.
Zhao Y, Zheng H, Yang S, Zhang X, Dong W, Shi Y, et al.
Immunopharmacol Immunotoxicol
. 2021 Nov;
44(1):58-66.
PMID: 34845949
Aim: Acute lung injury (ALI) and resultant acute respiratory distress syndrome (ARDS) are detrimental inflammatory disease associated with high rates of morbidity and mortality due to a lack of effective...
4.
Dong W, Zhu Y, Du Y, Wang L, Feng X, Ma S
Clin Respir J
. 2019 Dec;
14(4):345-352.
PMID: 31876095
Introduction: Chronic obstructive pulmonary disease (COPD) is associated with poor prognosis in non-small cell lung cancer (NSCLC) patients. There are limited data about the impact of severe-to-very severe COPD on...
5.
Dong W, Zhu Y, Du Y, Ma S
Clin Respir J
. 2019 Jun;
13(8):499-504.
PMID: 31172658
Introduction: Chronic obstructive pulmonary disease (COPD) is associated with risk of venous thromboembolism (VTE) events. A detailed understanding of which clinical features of COPD increase risk of VTE events is...
6.
Dong W, Du Y, Ma S
Int J Chron Obstruct Pulmon Dis
. 2018 Dec;
13:3805-3812.
PMID: 30538442
Background: The aim of the study was to investigate if first-line chemotherapy improves total survival time in non-small-cell lung cancer (NSCLC) patients complicated with severe to very severe COPD. Materials...
7.
Wang Z, Guo H, Dong W
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
. 2015 Jan;
49(11):915.
PMID: 25598370
No abstract available.